Leica Biosystems and Leeds Hospital Establish Strategic Partnership to Provide Quantifiable Benefits of Digital Pathology
United Kingdom – Leica Biosystems and Leeds Teaching Hospitals NHS Trust/University of Leeds recently announced that they have formalized a collaborative relationship on Digital Pathology (DP). Their collective goal is to demonstrate the substantial clinical and productivity benefits of deploying Digital Pathology on a large scale. To this end, Leeds has begun the full adoption of Leica Biosystems Aperio Digital Pathology in a clinical setting across all sub-specialties.
“Leeds is excited to partner with Leica Biosystems. Digital Pathology has many benefits and it is becoming an essential technology for a modern pathology service. We believe that the link between the histology workflow, downstream imaging and slide review process is critical for the optimal use of Digital Pathology,” said Dr. Darren Treanor, Consultant Pathologist, and lead of the Leeds Digital Pathology Group. “Leica Biosystems understands the complete laboratory workflow required to implement and develop digital pathology. Working together will help us realize the full potential of digital pathology; while meeting the needs of our researchers, pathologists and patients.”
“Leica Biosystems is happy and honored to have a dedicated partner such as Leeds. For thirteen years, Leeds has been a leading institution in Digital Pathology on the world stage. It is one of the largest Whole Slide Imaging (WSI) scanning facilities in the world,” stated Jerome Clavel, Vice President and General Manager of Leica Biosystems Pathology Imaging Business. “We have a long history of working with Leeds. This formalized partnership is a natural progression of our long-standing collaboration. With the experience gained from working with scientists and clinicans from Leeds, we expect to accelerate our progress towards the mainstream adoption of Digital Pathology, with ever-improved solutions and systems.“
The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA nor are the products available in the United States.
About Leica Biosystems
Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.
About University of Leeds
The University of Leeds is one of the largest higher education institutions in the UK, with more than 31,000 students from 147 different countries, and a member of the Russell Group research-intensive universities. We are a top 10 university for research and impact power in the UK, according to the 2014 Research Excellence Framework, and positioned as one of the top 100 best universities in the world in the 2015 QS World University Rankings. We are The Times and The Sunday Times University of the Year 2017 www.leeds.ac.uk
About Leeds Teaching Hospitals NHS Trust
The Leeds Teaching Hospitals NHS Trust is one of the largest in England and includes two major teaching hospitals, Leeds General Infirmary and St James’s University Hospital. It has a total budget of over £1.1 billion, employs more than 16,000 staff across seven main sites, and treats around 1.5 million patients a year.
Source: Leica Biosystems
